aid: avistone
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/avistone.png
name: Avistone
description: 'Beijing Avistone Biotechnology Co., Ltd. is a commercial-stage innovative biopharmaceutical
  company headquartered in Beijing, China, focused on the research, development, and commercialization of
  first-in-class and best-in-class oncology therapies. Founded in 2012 (originally Beijing Pearl Biotechnology)
  and renamed Avistone in 2018, the company has two approved cancer drugs on the market: Vebreltinib (万比锐®),
  a MET inhibitor approved for non-small cell lung cancer and glioma indications and included in China''s
  National Reimbursement Drug List, and Andamertinib (安比锐®), an EGFR exon 20 insertion inhibitor approved
  in 2026 for advanced NSCLC. Avistone maintains a pipeline of additional candidates (ANS01 through ANS09)
  across solid-tumor indications and is backed by IDG Capital. The company publishes no public developer
  API or programmatic surface; this profile captures its corporate and investor identity.'
url: https://raw.githubusercontent.com/api-evangelist/avistone/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- idg-capital
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Healthcare
- Biopharmaceutical
- Oncology
- Pharmaceuticals
- Drug Development
- Biotechnology
- Cancer Therapeutics
- China
apis: []
common:
- type: Website
  url: https://en.avistonebio.com
- type: Website
  url: https://www.avistonebio.com
- type: PrivacyPolicy
  url: https://www.avistonebio.com/privacy_policy.html
- type: Careers
  url: https://www.avistonebio.com/join_index.html
- type: InvestorRelations
  url: https://www.avistonebio.com/investor_index.html
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence